Drug Discrimination in Methadone-Maintained Humans Study 3
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Drug Discrimination in Methadone-Maintained Humans Study 3 is a clinical trial[1].
Key Facts
- Drug Discrimination in Methadone-Maintained Humans Study 3 is in the country of United States[2].
- Drug Discrimination in Methadone-Maintained Humans Study 3's instance of is recorded as clinical trial[3].
- Drug Discrimination in Methadone-Maintained Humans Study 3's start time is recorded as +2010-02-28T00:00:00Z[4].
- Drug Discrimination in Methadone-Maintained Humans Study 3's end time is recorded as +2012-10-31T00:00:00Z[5].
- Drug Discrimination in Methadone-Maintained Humans Study 3's sponsor is recorded as University of Arkansas[6].
- Drug Discrimination in Methadone-Maintained Humans Study 3's number of participants is recorded as {'unit': '1', 'amount': '+9'}[7].
- Drug Discrimination in Methadone-Maintained Humans Study 3's title is recorded as Drug Discrimination in Methadone-Maintained Humans Study 3[8].
- Drug Discrimination in Methadone-Maintained Humans Study 3's short name is recorded as OMDD3[9].
- Drug Discrimination in Methadone-Maintained Humans Study 3's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Drug Discrimination in Methadone-Maintained Humans Study 3's ClinicalTrials.gov ID is recorded as NCT01068847[11].
- Drug Discrimination in Methadone-Maintained Humans Study 3's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as methadone hydrochloride[13].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as tizanidine[14].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as naloxone[15].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as nifedipine[16].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as verapamil[17].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research intervention is recorded as cycloserine[18].
- Drug Discrimination in Methadone-Maintained Humans Study 3's clinical trial phase is recorded as phase I clinical trial[19].
- Drug Discrimination in Methadone-Maintained Humans Study 3's research subject recruitment status is recorded as completed[20].
- Drug Discrimination in Methadone-Maintained Humans Study 3's study type is recorded as interventional study[21].